The second option is RRSO between 35‐40 years old (BRCA1) and 40‐45 years old (BRCA2), as currently recommended in national and international guidelines.21, 22 The third option is risk‐reducing salpingectomy upon completion of childbearing with delayed oophorectomy between 40‐45 (BRCA1) and 45‐50 years old (BRCA2), which has not been proven effective yet in terms of improved quality of life or safe in terms of ovarian cancer risk. The gene discussed is BRCA1; the disease is ovarian carcinoma.